Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication
The current outbreak of Ebola virus (EBOV) in West Africa has claimed the lives of more than 15,000 people and highlights an urgent need for therapeutics capable of preventing virus replication. In this study we screened known nucleoside analogues for their ability to interfere with EBOV replication...
Main Authors: | Olivier Reynard, Xuan-Nhi Nguyen, Nathalie Alazard-Dany, Véronique Barateau, Andrea Cimarelli, Viktor E. Volchkov |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-12-01
|
Series: | Viruses |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4915/7/12/2934 |
Similar Items
-
A Multi-Filovirus Vaccine Candidate: Co-Expression of Ebola, Sudan, and Marburg Antigens in a Single Vector
by: Sarah Sebastian, et al.
Published: (2020-05-01) -
Correlates of Immunity to Filovirus Infection
by: Sina Bavari, et al.
Published: (2011-06-01) -
Marburg virus disease: A summary for clinicians
by: Mark G. Kortepeter, et al.
Published: (2020-10-01) -
The Role of Cytokines and Chemokines in Filovirus Infection
by: Sandra L. Bixler, et al.
Published: (2015-10-01) -
Animal models for Ebola and Marburg virus infections
by: Eri eNakayama, et al.
Published: (2013-09-01)